Insights
into statistical
evidence
Recent Publication
Martin Scott, S. Gsteiger, O. Dohring, et al. | Navigating Priorities, Statistical Rigor, and Decision-Making on Multiplicity Questions in the Context of the EU Joint Clinical Assessment. | Statistics in Biopharmaceutical Research, 2026 | Category: JCA
Multiplicity in EU Joint Clinical Assessment
Multiplicity in EU Joint Clinical Assessment:
Multiplicity is emerging as a key methodological challenge within the EU Joint Clinical Assessment (JCA) framework. While regulatory settings focus on hypothesis testing and Type I error control, HTA decision-making requires a broader perspective on evidence interpretation …
Your next evidence challenge
Have an evidence question?